HUP0001607A3 - Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds - Google Patents
Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compoundsInfo
- Publication number
- HUP0001607A3 HUP0001607A3 HU0001607A HUP0001607A HUP0001607A3 HU P0001607 A3 HUP0001607 A3 HU P0001607A3 HU 0001607 A HU0001607 A HU 0001607A HU P0001607 A HUP0001607 A HU P0001607A HU P0001607 A3 HUP0001607 A3 HU P0001607A3
- Authority
- HU
- Hungary
- Prior art keywords
- compounds
- preparation
- pharmaceutical compositions
- compositions containing
- thienopyrimidine derivatives
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- RBNBDIMXFJYDLQ-UHFFFAOYSA-N thieno[3,2-d]pyrimidine Chemical class C1=NC=C2SC=CC2=N1 RBNBDIMXFJYDLQ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19632423A DE19632423A1 (de) | 1996-08-12 | 1996-08-12 | Thienopyrimidine |
| PCT/EP1997/004139 WO1998006722A1 (de) | 1996-08-12 | 1997-07-30 | Thienopyrimidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0001607A2 HUP0001607A2 (hu) | 2000-10-28 |
| HUP0001607A3 true HUP0001607A3 (en) | 2002-09-30 |
Family
ID=7802392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0001607A HUP0001607A3 (en) | 1996-08-12 | 1997-07-30 | Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6110920A (hu) |
| EP (1) | EP0920431B1 (hu) |
| JP (1) | JP4405593B2 (hu) |
| KR (1) | KR100502271B1 (hu) |
| CN (1) | CN1081638C (hu) |
| AR (1) | AR009052A1 (hu) |
| AT (1) | ATE233265T1 (hu) |
| AU (1) | AU725227B2 (hu) |
| BR (1) | BR9711062A (hu) |
| CA (1) | CA2263561C (hu) |
| CZ (1) | CZ287772B6 (hu) |
| DE (2) | DE19632423A1 (hu) |
| DK (1) | DK0920431T3 (hu) |
| ES (1) | ES2191192T3 (hu) |
| HK (1) | HK1021731A1 (hu) |
| HU (1) | HUP0001607A3 (hu) |
| IL (1) | IL128504A (hu) |
| NO (1) | NO990643L (hu) |
| NZ (1) | NZ334600A (hu) |
| PL (1) | PL190174B1 (hu) |
| PT (1) | PT920431E (hu) |
| RU (1) | RU2199541C2 (hu) |
| SI (1) | SI0920431T1 (hu) |
| SK (1) | SK282823B6 (hu) |
| TR (1) | TR199900308T2 (hu) |
| TW (1) | TW359672B (hu) |
| UA (1) | UA55421C2 (hu) |
| WO (1) | WO1998006722A1 (hu) |
| ZA (1) | ZA977156B (hu) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19819023A1 (de) | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidine |
| US6339106B1 (en) | 1999-08-11 | 2002-01-15 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
| US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
| US6331571B1 (en) | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
| US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
| EP1167367A4 (en) * | 1999-03-30 | 2002-04-24 | Nippon Soda Co | THIENOPYRIMIDINE COMPOUNDS AND SALTS THEREOF, AND PROCESS FOR THE PREPARATION THEREOF |
| US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| DE10031585A1 (de) * | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 2-Aminoalkyl-thieno[2,3-d]pyrimidine |
| WO2002026745A1 (fr) * | 2000-09-29 | 2002-04-04 | Nippon Soda Co., Ltd. | Composes de thienopyrimidine et leurs sels et procede de preparation |
| CA2437085A1 (en) * | 2001-02-02 | 2002-08-15 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| WO2002083631A1 (en) | 2001-04-13 | 2002-10-24 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
| WO2002088138A1 (en) * | 2001-04-30 | 2002-11-07 | Bayer Corporation | Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines |
| JPWO2003035653A1 (ja) * | 2001-10-26 | 2005-02-10 | 日本曹達株式会社 | ピリドチエノピリミジン化合物およびその塩 |
| US7153412B2 (en) | 2001-12-28 | 2006-12-26 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Electrodes, electrochemical elements, gas sensors, and gas measurement methods |
| US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| US7276529B2 (en) | 2002-03-20 | 2007-10-02 | Celgene Corporation | Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| US7208516B2 (en) | 2002-03-20 | 2007-04-24 | Celgene Corporation | Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| AR044743A1 (es) * | 2002-09-26 | 2005-10-05 | Nihon Nohyaku Co Ltd | Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos, |
| GB0320300D0 (en) * | 2003-08-29 | 2003-10-01 | Cancer Rec Tech Ltd | Pyrimidothiophene compounds |
| DE10351436A1 (de) * | 2003-11-04 | 2005-06-09 | Merck Patent Gmbh | Verwendung von Thienopyrimidinen |
| GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| GB0420719D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| TWI417095B (zh) * | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途 |
| TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| TW200900065A (en) * | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| US9603848B2 (en) | 2007-06-08 | 2017-03-28 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
| US9114138B2 (en) | 2007-09-14 | 2015-08-25 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones |
| EA019085B1 (ru) | 2007-09-14 | 2014-01-30 | Янссен Фармасьютикалз, Инк. | 1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны |
| TW200927731A (en) * | 2007-09-14 | 2009-07-01 | Ortho Mcneil Janssen Pharm | 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones |
| JP5433582B2 (ja) * | 2007-11-14 | 2014-03-05 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | イミダゾ［１，２−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体の正のアロステリック調節因子としてのその使用 |
| US20100227853A1 (en) * | 2008-04-18 | 2010-09-09 | Trustees Of Boston College | Inhibitors of cyclic amp phosphodiesterases |
| US8586733B2 (en) | 2008-07-31 | 2013-11-19 | Senomyx, Inc. | Processes and intermediates for making sweet taste enhancers |
| WO2010025890A1 (en) | 2008-09-02 | 2010-03-11 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| AU2009304293B2 (en) | 2008-10-16 | 2012-04-26 | Addex Pharma S.A. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| AU2009319387B2 (en) | 2008-11-28 | 2012-05-10 | Addex Pharma S.A. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| CA2760259C (en) | 2009-05-12 | 2018-05-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| JP5634506B2 (ja) | 2009-05-12 | 2014-12-03 | ジャンセン ファーマシューティカルズ， インコーポレイテッド | １，２，３−トリアゾロ［４，３−ａ］ピリジン誘導体ならびに神経障害および精神障害の治療または予防のためのその使用 |
| JP5852666B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| JP5852665B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| ES2552455T3 (es) | 2010-11-08 | 2015-11-30 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
| JP6027611B2 (ja) | 2011-07-19 | 2016-11-16 | インフィニティー ファーマシューティカルズ， インコーポレイテッド | 複素環式化合物及びその使用 |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| KR20150041040A (ko) | 2012-08-06 | 2015-04-15 | 세노믹스, 인코포레이티드 | 단맛 향미 개질제 |
| JO3155B1 (ar) | 2013-02-19 | 2017-09-20 | Senomyx Inc | معدِّل نكهة حلوة |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| LT3096790T (lt) | 2014-01-21 | 2019-10-10 | Janssen Pharmaceutica, N.V. | Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas |
| WO2015110435A1 (en) | 2014-01-21 | 2015-07-30 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| MX2016014384A (es) | 2014-06-23 | 2017-01-20 | Celgene Corp | Apremilast para el tratamiento de una enfermedad del higado o una anormalidad en la funcion del higado. |
| SG11201804901WA (en) | 2015-12-22 | 2018-07-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
| US10588894B2 (en) * | 2017-06-21 | 2020-03-17 | SHY Therapeutics LLC | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| US11945813B2 (en) | 2018-08-07 | 2024-04-02 | Firmenich Incorporated | 5-substituted 4-amino-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof |
| CN116178374A (zh) * | 2023-01-13 | 2023-05-30 | 河北医科大学 | 小电导钙激活钾离子通道激动剂及其合成和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1570494A (en) * | 1975-11-28 | 1980-07-02 | Ici Ltd | Thienopyrimidine derivatives and their use as pesticides |
| ZA782648B (en) * | 1977-05-23 | 1979-06-27 | Ici Australia Ltd | The prevention,control or eradication of infestations of ixodid ticks |
| JP2657760B2 (ja) * | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | ４−アミノキナゾリン誘導体およびそれを含有する医薬品 |
| US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
-
1996
- 1996-08-12 DE DE19632423A patent/DE19632423A1/de not_active Withdrawn
-
1997
- 1997-07-30 PL PL97331538A patent/PL190174B1/pl not_active IP Right Cessation
- 1997-07-30 AT AT97940047T patent/ATE233265T1/de not_active IP Right Cessation
- 1997-07-30 NZ NZ334600A patent/NZ334600A/xx unknown
- 1997-07-30 AU AU42035/97A patent/AU725227B2/en not_active Ceased
- 1997-07-30 KR KR10-1999-7001153A patent/KR100502271B1/ko not_active IP Right Cessation
- 1997-07-30 DE DE59709404T patent/DE59709404D1/de not_active Expired - Lifetime
- 1997-07-30 ES ES97940047T patent/ES2191192T3/es not_active Expired - Lifetime
- 1997-07-30 BR BR9711062A patent/BR9711062A/pt not_active IP Right Cessation
- 1997-07-30 TR TR1999/00308T patent/TR199900308T2/xx unknown
- 1997-07-30 SI SI9730518T patent/SI0920431T1/xx unknown
- 1997-07-30 SK SK164-99A patent/SK282823B6/sk unknown
- 1997-07-30 PT PT97940047T patent/PT920431E/pt unknown
- 1997-07-30 DK DK97940047T patent/DK0920431T3/da active
- 1997-07-30 WO PCT/EP1997/004139 patent/WO1998006722A1/de not_active Application Discontinuation
- 1997-07-30 JP JP50934398A patent/JP4405593B2/ja not_active Expired - Fee Related
- 1997-07-30 CZ CZ1999448A patent/CZ287772B6/cs not_active IP Right Cessation
- 1997-07-30 HU HU0001607A patent/HUP0001607A3/hu unknown
- 1997-07-30 EP EP97940047A patent/EP0920431B1/de not_active Expired - Lifetime
- 1997-07-30 CN CN97197179A patent/CN1081638C/zh not_active Expired - Fee Related
- 1997-07-30 RU RU99104796/04A patent/RU2199541C2/ru not_active IP Right Cessation
- 1997-07-30 CA CA002263561A patent/CA2263561C/en not_active Expired - Fee Related
- 1997-07-30 US US09/230,806 patent/US6110920A/en not_active Expired - Fee Related
- 1997-07-30 UA UA99031300A patent/UA55421C2/uk unknown
- 1997-07-30 IL IL12850497A patent/IL128504A/xx not_active IP Right Cessation
- 1997-08-11 ZA ZA9707156A patent/ZA977156B/xx unknown
- 1997-08-11 TW TW086111481A patent/TW359672B/zh active
- 1997-08-12 AR ARP970103649A patent/AR009052A1/es unknown
-
1999
- 1999-02-11 NO NO990643A patent/NO990643L/no not_active Application Discontinuation
-
2000
- 2000-01-31 HK HK00100583A patent/HK1021731A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0001607A3 (en) | Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds | |
| HUP9904680A3 (en) | Thienopyrimidine derivatives, pharmaceutical compositions containing them and process for their preparation | |
| HUP9700358A3 (en) | New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
| HUP9602122A3 (en) | Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
| IL120141A (en) | Substituted quinazoline derivatives process for their preparation and pharmaceutical compositions containing them | |
| HUT72448A (en) | O-, n- ors-containing heterobicyclic compounds, pharmaceutical compositions comprising them and process for their preparation | |
| HUP0003844A3 (en) | Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them | |
| IL117598A (en) | Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
| EP0811595A4 (en) | HYDROCHALCONE DERIVATIVES, COSMETIC COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING SUCH DERIVATIVES OR COMPOSITIONS | |
| HUP9801044A3 (en) | Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP9601033A2 (en) | Benzofurane derivatives, process for their preparation, use of them as intermediate and pharmaceutical compositions containing the compounds | |
| HUP9801045A3 (en) | Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation | |
| ZA962916B (en) | New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds | |
| HUP0100488A3 (en) | Thienopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
| HUP9602635A3 (en) | 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP9901326A3 (en) | Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions | |
| HUP9801993A3 (en) | Ascomycin derivatives and their use for preparation of pharmaceutical compositions, process for their preparation and pharmaceutical compositions containing them | |
| HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
| HUP9802393A3 (en) | Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates | |
| CZ92295A3 (en) | Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof | |
| CZ346595A3 (en) | Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof | |
| HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds |